Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.485
-0.060 (-3.88%)
Sep 25, 2026, 12:41 PM EDT - Market open
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $6.65 million as of September 25, 2026. Its market cap has increased by 248.09% in one year.
Market Cap
6.65M
Enterprise Value
-1.65M
1-Year Change
248.09%
Ranking
Category
Stock Price
$1.49
ChartMarket Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $6.65M, a decrease of -100.00%. That is a compound annual growth rate of -82.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 6.65M | 78.92% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 7.66M |
| Evogene | 7.60M |
| Skye Bioscience | 7.57M |
| CollPlant Biotechnologies | 7.28M |
| Acurx Pharmaceuticals | 7.17M |
| Bolt Biotherapeutics | 7.15M |
| AIM ImmunoTech | 6.56M |
| Processa Pharmaceuticals | 6.30M |